BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3421508)

  • 1. Altered in vitro hemostasis, clotting, and thrombolysis after oral nifedipine in normal volunteers.
    Rademaker M; Meyrick-Thomas RH; Kirby JD; Kovacs IB
    Angiology; 1988 Aug; 39(8):747-51. PubMed ID: 3421508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-platelet effect of nifedipine in patients with systemic sclerosis.
    Rademaker M; Meyrick Thomas RH; Kirby JD; Kovacs IB
    Clin Exp Rheumatol; 1992; 10(1):57-62. PubMed ID: 1551280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin is a more potent stimulator of thrombolysis than inhibitor of haemostasis.
    Görög P; Kovacs IB
    Haemostasis; 1986; 16(5):337-45. PubMed ID: 3536684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostatic abnormalities in Sneddon's syndrome.
    Mayou SC; Kovacs IB; Ridler CD; Kirby JD
    Angiology; 1992 Apr; 43(4):342-9. PubMed ID: 1558320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new, ideal technique to monitor thrombolytic therapy.
    Görög P
    Angiology; 1986 Feb; 37(2):99-105. PubMed ID: 3954159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a defibrotide-heparin combination on some measures of haemostasis in healthy volunteers.
    Pogliani EM; Salvatore M; Fowst C; Girardello R; Marelli C
    J Int Med Res; 1989; 17(1):36-40. PubMed ID: 2707475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influences of earthworm extract G-90 on haematological and haemostatic parameters in Wistar rats.
    Matausic-Pisl M; Tomicic M; Micek V; Grdisa M
    Eur Rev Med Pharmacol Sci; 2011 Jan; 15(1):71-8. PubMed ID: 21381501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of extrinsic hemostasis activation by low-molecular-weight heparin.
    Stief TW
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):633-7. PubMed ID: 17102649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of nifedipine on human red cell metabolism and blood coagulation.
    Meky N
    J Med; 1994; 25(1-2):17-22. PubMed ID: 7930956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of endothelin-1 on some hemostatic parameters in normotensive rats.
    Pietraszek M; Chabielska E; Azzadin A; Pawlak R; Buczko W
    Acta Physiol Hung; 1996; 84(3):329-30. PubMed ID: 9219627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effect of activated recombinant factor VII (rFVIIa) on coagulation properties of human blood at hypothermic temperatures.
    Kheirabadi BS; Delgado AV; Dubick MA; Scherer MR; Fedyk CG; Holcomb JB; Pusateri AE
    J Trauma; 2007 Nov; 63(5):1079-86. PubMed ID: 17993954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Primary Mast Cell Disease on Hemostasis and Erythropoiesis.
    Seidel H; Hertfelder HJ; Oldenburg J; Kruppenbacher JP; Afrin LB; Molderings GJ
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro comparison of dabigatran, unfractionated heparin, and low-molecular-weight heparin in preventing thrombus formation on mechanical heart valves.
    Maegdefessel L; Linde T; Krapiec F; Hamilton K; Steinseifer U; van Ryn J; Raaz U; Buerke M; Werdan K; Schlitt A
    Thromb Res; 2010 Sep; 126(3):e196-200. PubMed ID: 20659761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous measurement of all thrombosis parameters from native human blood: usefulness in monitoring efficacy and complications of thrombolytic therapy.
    Kovacs IB; Görög P
    Angiology; 1990 Oct; 41(10):829-35. PubMed ID: 2121073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic change of coagulation and anticoagulation markers of patients with acute cerebral infarction during intravenous urokinase thrombolysis.
    Ji X; Meng R; Zhou J; Ling F; Jia J
    Neurol Res; 2006 Jan; 28(1):46-9. PubMed ID: 16464362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of antithrombotic properties of sodium ibuprofen.
    Esquivel CO; Bergqvist D; Björck CG; Carson SN; Nilsson B
    Thromb Haemost; 1982 Aug; 48(1):87-90. PubMed ID: 7135348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of thrombolysis on platelets and coagulation].
    Helft G; Abdelouahed M; Vacheron A; Lecompte T; Samama MM
    Ann Cardiol Angeiol (Paris); 1995 Sep; 44(7):354-60. PubMed ID: 8561440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
    Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamins and minerals that affect hemostasis and antithrombotic therapies.
    Rebecca Couris R
    Thromb Res; 2005; 117(1-2):25-31; discussion 39-42. PubMed ID: 16257439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.